• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用生物发光快速检测体外和巨噬细胞内的抗结核药物活性。

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.

机构信息

Microbiology, Department of Medicine, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.

出版信息

J Antimicrob Chemother. 2012 Feb;67(2):404-14. doi: 10.1093/jac/dkr472. Epub 2011 Nov 17.

DOI:10.1093/jac/dkr472
PMID:22101217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3254196/
Abstract

OBJECTIVES

Tuberculosis drug development is hampered by the slow growth of Mycobacterium tuberculosis. Bioluminescence, light produced by an enzymatic reaction, constitutes a rapid and highly sensitive measurement of cell metabolic function that can be used as an indirect marker of cell viability in drug screening assays. The aim of this work was to validate and standardize the use of luminescent M. tuberculosis strains to test the activity of antibacterial drugs in vitro and inside macrophages in a 96-well format.

METHODS

We have used strains that express the bacterial lux operon and therefore do not require exogenous substrate to produce light, as well as strains expressing the firefly luciferase that need luciferin substrate. Results were compared with those obtained using the resazurin reduction assay and cfu plating.

RESULTS

Using bioluminescence we were able to reduce the time required to measure the MIC and bactericidal concentrations of antimicrobials to just 3 and 6 days, respectively. Furthermore, antibacterial activity against intracellular mycobacteria was detected within 2 days post-infection. Results were comparable to those obtained by conventional methods.

CONCLUSIONS

We have developed a simple and rapid method for screening antimycobacterial drugs in culture and in macrophages. The use of autoluminescent bacteria also facilitates the determination of growth and inhibition kinetics. The method is cost-effective, can easily be adapted to a larger scale and is amenable to automation. Current efforts are directed towards applying this technology to drug screening in vivo.

摘要

目的

分枝杆菌缓慢的生长速度阻碍了抗结核药物的研发。生物发光是一种酶促反应产生的光,可作为细胞代谢功能的快速、高灵敏度测量指标,可作为药物筛选测定中细胞活力的间接标志物。本研究旨在验证和标准化发光分枝杆菌菌株在 96 孔格式中体外和巨噬细胞内检测抗菌药物活性的用途。

方法

我们使用了表达细菌 lux 操纵子的菌株,因此不需要外源性底物来产生光,以及表达荧光素酶的菌株,需要 luciferin 底物。结果与使用 Resazurin 还原测定法和 CFU 平板获得的结果进行了比较。

结果

使用生物发光,我们能够将测量 MIC 和杀菌浓度所需的时间分别缩短至 3 天和 6 天。此外,在感染后 2 天内即可检测到针对细胞内分枝杆菌的抗菌活性。结果与传统方法相当。

结论

我们开发了一种简单快速的方法,用于在培养物和巨噬细胞中筛选抗分枝杆菌药物。自发光细菌的使用也便于确定生长和抑制动力学。该方法具有成本效益,易于扩展,并且适用于自动化。目前的努力方向是将该技术应用于体内药物筛选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/0e49cdf02d30/dkr47204.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/cd9132aa4f95/dkr47201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/00e99617bf0d/dkr47202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/9ac273c0ba6c/dkr47203.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/0e49cdf02d30/dkr47204.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/cd9132aa4f95/dkr47201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/00e99617bf0d/dkr47202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/9ac273c0ba6c/dkr47203.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f951/3254196/0e49cdf02d30/dkr47204.jpg

相似文献

1
Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.利用生物发光快速检测体外和巨噬细胞内的抗结核药物活性。
J Antimicrob Chemother. 2012 Feb;67(2):404-14. doi: 10.1093/jac/dkr472. Epub 2011 Nov 17.
2
Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.表达萤火虫荧光素酶的生物发光金色分枝杆菌用于体外和感染巨噬细胞中抗分枝杆菌药物的快速高通量筛选。
Biochem Biophys Res Commun. 2000 Dec 20;279(2):457-61. doi: 10.1006/bbrc.2000.3957.
3
Reporter gene technology to assess activity of antimycobacterial agents in macrophages.利用报告基因技术评估巨噬细胞中抗分枝杆菌药物的活性。
Antimicrob Agents Chemother. 1996 Jun;40(6):1542-4. doi: 10.1128/AAC.40.6.1542.
4
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.利用荧光素酶报告噬菌体快速评估结核分枝杆菌的药物敏感性
Science. 1993 May 7;260(5109):819-22. doi: 10.1126/science.8484123.
5
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis.利用自发光结核分枝杆菌测定化合物抗分枝杆菌效力的简单快速方法。
Antimicrob Agents Chemother. 2014 Oct;58(10):5801-8. doi: 10.1128/AAC.03205-14. Epub 2014 Jul 21.
6
Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.利用荧光素酶报告噬菌体和布朗克斯盒基于快速胶片法测定结核分枝杆菌菌株的抗生素敏感性
J Clin Microbiol. 1999 Apr;37(4):1144-9. doi: 10.1128/JCM.37.4.1144-1149.1999.
7
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.自发光结核分枝杆菌用于快速、实时、非侵入性评估药物和疫苗的疗效。
PLoS One. 2012;7(1):e29774. doi: 10.1371/journal.pone.0029774. Epub 2012 Jan 11.
8
Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.开发一种用于筛选能够抑制结核分枝杆菌在人巨噬细胞中生长的新型化合物的细胞内筛选方法。
Antimicrob Agents Chemother. 2015 Oct 26;60(1):640-5. doi: 10.1128/AAC.01920-15. Print 2016 Jan.
9
A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.一种基于荧光素酶的检测方法,用于快速评估药物对结核分枝杆菌的活性,包括监测巨噬细胞活力。
J Microbiol Methods. 2014 Nov;106:146-150. doi: 10.1016/j.mimet.2014.08.015. Epub 2014 Sep 3.
10
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.用于高通量抗分枝杆菌药物发现的体外生物发光筛选(Bio-Siv)测定法。
Antimicrob Agents Chemother. 1996 Jun;40(6):1536-41. doi: 10.1128/AAC.40.6.1536.

引用本文的文献

1
Toward Virulence Inhibition: Beyond Cell Wall.走向毒力抑制:超越细胞壁
Microorganisms. 2024 Dec 26;13(1):21. doi: 10.3390/microorganisms13010021.
2
Quantification of Mycobacterium tuberculosis Growth in Cell-Based Infection Assays by Time-Lapse Fluorescence Microscopy.基于延时荧光显微镜的细胞感染实验中结核分枝杆菌生长的定量分析。
Methods Mol Biol. 2024;2813:167-188. doi: 10.1007/978-1-0716-3890-3_12.
3
Nano-Delivery System of Ethanolic Extract of Propolis Targeting via Aptamer-Modified-Niosomes.通过适配体修饰的脂质体靶向递送蜂胶乙醇提取物的纳米递送系统

本文引用的文献

1
Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections.非侵入性活体成像评估金黄色葡萄球菌和 USA300 耐甲氧西林金黄色葡萄球菌皮肤感染的免疫反应和抗菌治疗。
J Invest Dermatol. 2011 Apr;131(4):907-15. doi: 10.1038/jid.2010.417. Epub 2010 Dec 30.
2
Optimisation of bioluminescent reporters for use with mycobacteria.用于分枝杆菌的生物发光报告基因的优化。
PLoS One. 2010 May 24;5(5):e10777. doi: 10.1371/journal.pone.0010777.
3
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Nanomaterials (Basel). 2023 Jan 8;13(2):269. doi: 10.3390/nano13020269.
4
Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.结核病诊断中传统方法与新方法的改进
Front Microbiol. 2022 May 31;13:924410. doi: 10.3389/fmicb.2022.924410. eCollection 2022.
5
10-DEBC Hydrochloride as a Promising New Agent against Infection of .10-DEBC 盐酸盐作为一种有前途的新型抗感染药物
Int J Mol Sci. 2022 Jan 6;23(2):591. doi: 10.3390/ijms23020591.
6
Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.抗菌药物筛选方法的演变:分枝杆菌的当前前景
Microorganisms. 2021 Dec 10;9(12):2562. doi: 10.3390/microorganisms9122562.
7
Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production.利用黏着斑激酶诱导坏死性细胞死亡并抑制活性氧物质的产生。
Front Immunol. 2021 Oct 20;12:742370. doi: 10.3389/fimmu.2021.742370. eCollection 2021.
8
Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against .枸橼酸氯米酚对 表现出有效且持久的抗菌活性。
Int J Mol Sci. 2021 Oct 13;22(20):11029. doi: 10.3390/ijms222011029.
9
Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay.使用基于生物发光的中通量测定法筛选具有抗分枝杆菌活性的真菌
Front Microbiol. 2021 Sep 6;12:739995. doi: 10.3389/fmicb.2021.739995. eCollection 2021.
10
Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis.细胞壁降解酶对结核分枝杆菌协同作用的探索。
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0065921. doi: 10.1128/AAC.00659-21. Epub 2021 Jul 19.
利用重组发光菌株快速评估抗溃疡分枝杆菌的抗菌活性。
Antimicrob Agents Chemother. 2010 Jul;54(7):2806-13. doi: 10.1128/AAC.00400-10. Epub 2010 Apr 26.
4
Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis.一种用于评估结核分枝杆菌细胞内生长的中通量方法的验证
Clin Vaccine Immunol. 2010 Apr;17(4):513-7. doi: 10.1128/CVI.00446-09. Epub 2010 Jan 27.
5
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.利用无创伤生物发光成像来评估小鼠分枝杆菌的传播、杀菌药物的治疗作用和保护免疫。
Microbes Infect. 2009 Dec;11(14-15):1114-21. doi: 10.1016/j.micinf.2009.08.005. Epub 2009 Aug 12.
6
Streptomycin.链霉素
Tuberculosis (Edinb). 2008 Mar;88(2):162-3. doi: 10.1016/S1472-9792(08)70027-1.
7
Isoniazid.异烟肼
Tuberculosis (Edinb). 2008 Mar;88(2):112-6. doi: 10.1016/S1472-9792(08)70011-8.
8
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.用生物发光细菌测定达托霉素对小鼠耐甲氧西林和甲氧西林敏感金黄色葡萄球菌腹膜炎的快速杀菌活性。
Antimicrob Agents Chemother. 2007 May;51(5):1787-94. doi: 10.1128/AAC.00738-06. Epub 2007 Feb 16.
9
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.用于高通量筛选抗非复制型结核分枝杆菌化合物的低氧恢复试验
Antimicrob Agents Chemother. 2007 Apr;51(4):1380-5. doi: 10.1128/AAC.00055-06. Epub 2007 Jan 8.
10
Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.针对结核分枝杆菌的实验性化合物的快速微生物学和药理学评估。
Antimicrob Agents Chemother. 2006 Apr;50(4):1245-50. doi: 10.1128/AAC.50.4.1245-1250.2006.